Kindra, the modern wellness brand for menopause essentials launched from P&G Ventures and the venture engine M13, closed a $4.5 million seed funding round.
WHO: Helmed by CEO Catherine Balsam-Schwaber, Kindra's mission is to support women on their menopause journey through essential products, reliable information, and engaged community. Kindra is a leader in scientifically formulated, estrogen-free, and plant-powered menopause essentials. The brand is also a trusted go-to for reliable information and a supportive community. The vaginal lotion and naturally derived supplements were created to address some of the most common effects of menopause including sleeplessness, hot flashes, brain fog, vaginal dryness, and more. By approaching menopause thoughtfully and holistically, inside and out, Kindra is an ideal partner on the menopause journey, which many women will experience for up to 40% of their lives.
WHY: The new capital will be used to drive the continued growth and expansion of the business and marks an important moment in a category that has long been overlooked.
IN THEIR OWN WORDS: “The investor community is now drawn to the menopause category because they recognize the needs of this important demographic that is demanding attention and innovative solutions,” said Catherine Balsam-Schwaber, CEO, Kindra. “Kindra’s raise garnered an enthusiastic response from some of the most highly regarded funders because they believe in our science-backed premium products as well as our mission to speak out loud about menopause to help create a positive cultural shift. With our funders’ support, we are now poised to reach and serve the 6,000 women who enter menopause each day with even greater impact.”
“Female Founders Fund is excited to join Kindra in serving a large and underrepresented community, furthering our strong belief in the opportunity around innovating and improving the women's healthcare experience,” said Anu Duggal, Founding Partner, Female Founders Fund. “A sector that has long been ignored by venture capital, the women’s health space is one of the most promising areas of investment with women controlling 80% of all healthcare buying and usage decisions in a $3.5T healthcare industry. As per our 2020 Menopause Report, only 36% of women felt moderately or very prepared for menopause as many don’t understand menopause due to the stigma and lack of resources—with Kindra, we’re working to change this and reshape this mainstream sector for the benefit of its stakeholders.”
“Primetime Partners is thrilled to be on this journey with Kindra and invest in the fastest growing segment of our population,” said Abby Levy, Managing Partner and co-founder, Primetime Partners. “By 2030, there will be more women between the ages of 40 and 64 than women under 18—this demographic shift is fueling innovation focused on improving our quality of life as we age. With Catherine’s leadership, Kindra has the edge we are constantly looking for in emergent brands and new platforms to help deliver high-quality, clinically proven products that are directly available to consumers and actually relieve women and improve their overall experiences.”
DETAILS:
